DeLorean AI

RTMCM AI is a System of Intelligence (SOI) that develops mathematical profiles of patient journeys and treatment methodologies for specific pathophysiologies such as COPD, Coronary Heart Disease or Diabetes - sourcing information from claims, pharmacy, physician data, and external sources.

RTMCM AI is proactive at intervening and leveraging the insights generated to improve on disease prevention or progression, select optimal treatment, improve quality of care and longevity, and at the same time rationalize cost.
RTMCM AI generates real time predictions and interventive next best actions for care managers and medical directors to drive the most efficient treatment modalities to drive better health outcomes. RTMCM AI decreases per member per month (PMPM) as well as decreased medical loss ratio (MLR). DeLorean AI’s clients have decreased on average their PMPM for the sickest 1% by $100 and on average $10 PMPM.